Skip to main content
. Author manuscript; available in PMC: 2020 Nov 19.
Published in final edited form as: Urol Oncol. 2017 Sep 23;36(1):8.e17–8.e24. doi: 10.1016/j.urolonc.2017.08.027

Table 4:

Reclassification of risk of progression in 5122 patients with NMIBC assigned by EORTC categories and EAU categories

EAU Categories
Low-risk Intermediate-risk High-risk Total
EORTC Categories Low-risk 632 (55.3%) 510 (44.7%) 0  1142
Intermediate-risk 0 1514 (94.3%) 92 (5.7%) 1606
High-risk 0 278 (11.7%) 2096 (88.3) 2374